Identity Solutions Provider BIO-key Honored with Cybersecurity Excellence Awards in Four Categories
February 09 2022 - 7:57AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of Identity and Access Management (IAM) and Identity-Bound
Biometric (IBB) solutions, announced today that its solutions have
been honored as Gold badge winners in four product categories for
the 2022 Cybersecurity Excellence Awards. BIO-key’s PortalGuard
Identity-as-a-Service (IDaaS) platform was awarded the Gold badge
in the Identity and Access Management, Multi-factor Authentication,
and Single Sign-On product categories, while the company’s
Identity-Bound Biometrics were awarded the Gold badge in the
Biometrics category.
The Cybersecurity Excellence Awards are a worldwide program
produced by Cybersecurity Insiders and the Information Security
Community on LinkedIn to recognize and honor the world’s most
innovative cybersecurity organizations, products, and
professionals. Nominations are reviewed by cybersecurity experts at
both organizations, with voting taking place on the Cyber Security
Excellence Awards website.
“It’s an honor to be recognized by this group of cybersecurity
experts,” said Michael DePasquale, BIO-key Chairman and CEO.
“Winning in these product categories recognizes the hard work and
innovation that we’ve put into our solutions to continue to lead
the market by providing a unique combination of IAM and
Identity-Bound Biometrics for our customers.”
For over 25 years, organizations across all verticals,
especially in higher education, finance, government, and healthcare
have trusted BIO-key to help them eliminate passwords, secure
remote access, prevent cyberattacks, and improve productivity for
their IT teams. BIO-key's award-winning solutions offer an easy and
secure way to authenticate the identity of employees, customers,
and suppliers, while managing their access across devices and
applications.
To learn more about BIO-key’s solutions please visit the company
website.
About BIO-key International, Inc.
(www.BIO-key.com)
BIO-key has over two decades of expertise in providing
authentication technology for thousands of organizations and
millions of users and is revolutionizing authentication with
biometric-centric, multi-factor identity and access management
(IAM) solutions, including its PortalGuard IAM solution, that
provides convenient and secure access to devices, information,
applications, and high-value transactions. BIO-key’s patented
software and hardware solutions, with industry leading biometric
capabilities, enable large-scale on-premises and cloud-based
Identity-as-a-Service (IDaaS) solutions, as well as customized
enterprise solutions.
BIO-key Safe Harbor Statement All statements
contained in this press release other than statements of historical
facts are “forward-looking statements” as defined in the Private
Securities Litigation Reform Act of 1995 (the “Act”). The words
“estimate,” "project," "intends," "expects," "anticipates,"
"believes," and similar expressions are intended to identify
forward-looking statements. Such forward-looking statements are
made based on management's beliefs, as well as assumptions made by,
and information currently available to, management pursuant to the
"safe harbor" provisions of the Act. These statements are not
guarantees of future performance or events and are subject to risks
and uncertainties that may cause actual results to differ
materially from those included within or implied by such
forward-looking statements. These risks and uncertainties include,
without limitation, risks and uncertainties including our history
of losses and limited revenue; our ability to raise additional
capital; our ability to protect our intellectual property; changes
in business conditions; changes in our sales strategy and product
development plans; changes in the marketplace; continued services
of our executive management team; security breaches; competition in
the biometric technology industry; market acceptance of biometric
products generally and our products under development; our ability
to expand into Asia, Africa and other foreign markets; the duration
and severity of the current coronavirus COVID-19 pandemic and its
effect on our business operations, sales cycles, personnel, and the
geographic markets in which we operate; delays in the development
of products and statements of assumption underlying any of the
foregoing as well as other factors set forth under the caption see
"Risk Factors'' in our Annual Report on Form 10-K for the year
ended December 31, 2020 and other filings with the Securities and
Exchange Commission. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date made. Except as required by law, the Company undertakes
no obligation to disclose any revision to these forward-looking
statements whether as a result of new information, future events,
or otherwise. Additionally, there may be other factors of which the
Company is not currently aware that may affect matters discussed in
forward-looking statements and may also cause actual results to
differ materially from those discussed. In particular, the
consequences of the coronavirus outbreak to economic conditions and
the industry in general and the financial position and operating
results of our Company, in particular, have been material, are
changing rapidly, and cannot be predicted.
Engage with BIO-key Facebook – Corporate:
https://www.facebook.com/BIOkeyInternational/ LinkedIn – Corporate:
https://www.linkedin.com/company/bio-key-international Twitter –
Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR StockTwits:
BIO_keyIR
Media Contacts Tim Hurley, Erin Knapp Matter
Communications BIO-key@matternow.com 617-201-9152
Investor Contacts William Jones, David Collins
Catalyst IR BKYI@catalyst-ir.com 212-924-9800
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Apr 2023 to Apr 2024